tirzepatide half-life 5 days 116 hours Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial How Much Mounjaro Is Left

Your GoalBMI provider can help you choose the right option based on your health history

Drug Leads to Drastic Weight Loss with Diet and Exercise

SURMOUNT-5 Trial Results This Phase 3b, open-label trial randomized 751 adults with obesity (but without diabetes) to receive either: Maximum tolerated dose of tirzepatide (10 mg or 15 mg) Maximum tolerated dose of semaglutide (1.7 mg or 2.4 mg) Key findings at 72 weeks: The trial concluded that tirzepatide was superior to semaglutide with respect to reduction in body weight and waist circumference at week 72

Even more encouragingly, most people maintained the weight loss for the entire three-year study

Honestly, I went in expecting the usual disappointment, but Willow has been a revelation

I look after my muscle mass via resistance exercise and good protein intake